Billy W. Loo, Jr., MD, PhD, DABR

Clinical Focus

• Cancer > Head and Neck Cancer
• Cancer > Radiation Oncology
• Cancer > Radiation Oncology > Lung Cancer
• Radiation Oncology
• Radiation Therapy

Administrative Appointments

• Thoracic Radiation Oncology Program Leader, Radiation Oncology (2005 - present)

Honors and Awards

• Young Investigator Travel Grant, ECOG (2005)
• Basic Science Travel Grant, ASTRO (2005)
• Roentgen Resident/Fellow Research Award, RSNA (2004)
• Travel Grant Award, Best of ASCO Meeting, Denver, ASCO (2004)
• Molecular Biology in Clinical Oncology Workshop Scholarship, AACR (2004)

Professional Education

Postdoctoral Advisees

Frederick Lartey

Graduate & Fellowship Program Affiliations

• Radiation Oncology

Web Site Links

• Dr. Loo's Home Page

Research Interests

My main clinical specialties are radiation treatment of lung cancer and head & neck cancer, and I serve as the thoracic radiation oncology program leader.

My research interests include 4-D multimodality imaging to capture and compensate for breathing-induced motion using CT, PET, and MR; novel functional/metabolic imaging methods to characterize tumor biology; high-precision image-guided radiation therapy including 4-D IMRT, dynamic arc therapy, and radiosurgery.

Clinical Trials

• High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without a Biological Inhibitor in Treating Patients with Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery Recruiting
• Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed By Surgery Recruiting
• Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide Recruiting
• Feasibility of Using Real-time Cine-MRI for Treating Moving & Deforming Tumors Recruiting
• Identification of Secreted Markers for Tumor Hypoxia in Patients with Head and Neck or Lung Cancers Recruiting

Publications

• Cooperative group research efforts in thoracic malignancies 2009: a review from the 10th Annual International Lung Cancer Congress. Wakelee H, Loo BW, Kernstine KH, Putnam JB, Edelman MJ, Vokes EE, Schiller JH, Baas P, Saijo N, Adjei A, Goss G, Choy H, Gandara DR. Clin Lung Cancer. 2009; 10 (6): 395-404
• Intensity-Modulated Radiotherapy in the Treatment of Oropharyngeal Cancer: Clinical Outcomes and Patterns of Failure. Daly ME, Le QT, Maxim PG, Loo BW, Kaplan MJ, Fischbein NJ, Pinto H, Chang DT. Int J Radiat Oncol Biol Phys. 2009
• Re: "The safety and efficacy of robotic image-guided radiosurgery system treatment for intra- and extracranial lesions: A systematic review of the literature" [Radiotherapy and Oncology 89 (2009) 245-253]. Gibbs IC, Levendag PC, Fariselli L, Bondiau PY, Lartigau E, Loo BW, Gagnon GJ, Koong A. Radiother Oncol. 2009
• Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer. La TH, Filion EJ, Turnbull BB, Chu JN, Lee P, Nguyen K, Maxim P, Quon A, Graves EE, Loo BW, Le QT. Int J Radiat Oncol Biol Phys. 2009; 74 (5): 1335-41
• Safety and efficacy of percutaneous fiducial marker implantation for image-guided radiation therapy. Kothary N, Heit JJ, Louie JD, Kuo WT, Loo BW, Koong A, Chang DT, Hovsepian D, Sze DY, Hofmann LV. J Vasc Interv Radiol. 2009; 20 (2): 235-9